Trump Nominates Robert F. Kennedy Jr. for Health Department

LONDON (Reuters) – President-elect Donald Trump announced the nomination of Robert F. Kennedy Jr., an environmental activist known for spreading vaccine misinformation, to lead the U.S. Department of Health and Human Services, the country's foremost health agency.

Expert Reactions

Dr. Krishanthi Subramaniam, University of Liverpool

> "The nomination is alarming not just for the health of those in the U.S. but for the global community. Kennedy's history of denying vaccines could lead to increased vaccine hesitancy in the U.S. and potential outbreaks of preventable diseases."

Professor Johnjoe McFadden, University of Surrey

> "This nomination reflects a disregard for science in favor of misinformation. If confirmed, his policies could be disastrous, especially for American children."

Professor Simon Wessely, King’s College London

> "My jaw dropped at this nomination. Americans deserve much better than this."

Dr. David Elliman, Great Ormond Street Hospital for Children

> "While Kennedy's aim to tackle chronic conditions is commendable, his views on vaccination are concerning. He perpetuates myths about vaccine safety, which could harm vaccination programs globally. Vaccination has saved countless lives, and his leadership could reverse this progress."

Margaret Harris, WHO Spokesperson

> "It's up to WHO member states to set their policies. The U.S. plays a vital role in global health initiatives, and we continue to work closely to promote public health."

Lawrence Gostin, Georgetown Law

> "An RFK Jr. in key health agencies could jeopardize objective vaccine recommendations globally, impacting vaccines' availability and donations."

Rick Weissenstein, TD Cowen Analyst

> "We believe Kennedy Jr. may not get confirmed by the GOP-controlled Senate. Trump could resort to a recess appointment, but it would be temporary and subject to future confirmations."

JPMorgan Analysts

> "It's challenging to predict the impact of Kennedy's potential appointment on the healthcare sector without clarity on policy priorities."

Jefferies Analysts

> "Kennedy has stated he won't eliminate vaccines, but his stance on public health issues creates uncertainty among biotech investors regarding FDA actions and underlying science-driven decisions."